Pangenomic Health Inc. NARA
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 32.50K | 32.80K | 32.30K | 32.70K | 106.50K |
| Gross Profit | -32.50K | -32.80K | -32.30K | -32.70K | -106.50K |
| SG&A Expenses | 366.40K | 619.00K | 520.80K | 1.12M | 190.00K |
| Depreciation & Amortization | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 399.10K | 651.90K | 553.20K | 1.16M | 296.60K |
| Operating Income | -399.10K | -651.90K | -553.20K | -1.16M | -296.60K |
| Income Before Tax | -495.10K | -674.90K | -624.90K | -1.28M | -286.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -495.10K | -674.90K | -624.90K | -1.28M | -286.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -495.10K | -674.90K | -624.90K | -1.28M | -286.90K |
| EBIT | -399.10K | -651.90K | -553.20K | -1.16M | -296.60K |
| EBITDA | -399.00K | -651.80K | -553.10K | -1.16M | -296.50K |
| EPS Basic | -0.02 | -0.03 | -0.02 | -0.08 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.02 | -0.05 | -0.01 |
| EPS Diluted | -0.02 | -0.03 | -0.02 | -0.08 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.02 | -0.05 | -0.01 |
| Average Basic Shares Outstanding | 25.60M | 25.60M | 25.82M | 15.58M | 13.94M |
| Average Diluted Shares Outstanding | 25.60M | 25.60M | 25.82M | 15.58M | 13.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |